Histone Modification in NSCLC: Molecular Mechanisms and Therapeutic Targets

Lung cancer is the leading cause of cancer mortality in both genders, with non-small cell lung cancer (NSCLC) accounting for about 85% of all lung cancers. At the time of diagnosis, the tumour is usually locally advanced or metastatic, shaping a poor disease outcome. NSCLC includes adenocarcinoma, s...

Descripción completa

Detalles Bibliográficos
Autores principales: Bajbouj, Khuloud, Al-Ali, Abeer, Ramakrishnan, Rakhee K., Saber-Ayad, Maha, Hamid, Qutayba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584007/
https://www.ncbi.nlm.nih.gov/pubmed/34769131
http://dx.doi.org/10.3390/ijms222111701

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584007/
https://www.ncbi.nlm.nih.gov/pubmed/34769131
http://dx.doi.org/10.3390/ijms222111701

Ejemplares similares